Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top California based CEO’ operating in the Medical Device space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
Jiang Li
CEO of VivaLnk
Jiang has both passion and extensive experience in bringing innovative technology and products into the marketplace. He has held various senior management positions in both large high tech organizations and startup companies. Prior to joining VivaLnk, he was responsible for new product and technology development as the VP of engineering in Kovio and Thinfilm Electronics, leading printed electronics companies. Prior to that, he worked at AMD and the joint venture between AMD/Fujitsu, Spansion. As the VP of product engineering in Spansion, Jiang managed the major new product launches in Spansion. Jiang holds a Ph.D. degree from the University of Wisconsin-Madison, and a bachelor’s degree from Zhejiang University in China.
Follow Jiang Li:
About VivaLnk: VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Fei Li
Chief Executive Officer & Chairwoman of Hycor Biomedical LLC
Fei Li first joined Hycor in 2016 as President and Chairwoman of the Board. In September 2017, she became President and CEO of Hycor. Dr. Li has over 20 years’ experience in the fields of in vitro diagnostics (IVD), medical devices and Clinical Medicine. Over her distinguished career, Dr. Li has consistently demonstrated her ability to deliver results as she has led teams that improved product design, realized operational efficiency and recognized investment opportunities in the domestic and international healthcare sector. Dr. Li’s strengths include her extensive experience in building and empowering a team to manage through organizational growth to improve processes, decrease costs and accelerate business performance. Dr. Li also has extensive investment experience in the healthcare industry. She has successfully executed cross-border transactions and has been effective in managing pre- and post-investment activities between stakeholders and investment targets. Dr. Li has had the distinction of serving in multiple strategic roles including Chief Operating Officer for QuantumTech Medical Devices during 2016-2017, Chief Operating Office for Beyond Diagnostics Inc. between 2008 – 2011, Head of Business Development for Siemens Healthcare China from 2007 – 2008 and Director of Product Validation for Diagnostic Products Corporation from 2006 – 2007. Dr. Li holds a medical degree from San Yat-Sen University in Guangdong, China. In addition, she received a Ph.D. degree in Biomedical Sciences from the University of California, Riverside and a Master of Business Administration (M.B.A.) from the University of Redlands.
Follow Fei Li:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Paul Grand
CEO of MedTech Innovator
Follow Paul Grand:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Kristina Cahojova
Founder & CEO of kegg
Kristina Cahojova is the Founder and CEO of Kegg.
Follow Kristina Cahojova:
About kegg: Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising.
Joseph DeVivo
CEO of InTouch Health
Joseph M. DeVivo, Chief Executive Officer of InTouch Health, brings a proven track record of 30 years of extensive business leadership and 25 years of medical device experience, ranging from small startups to large corporations. Prior to joining InTouch Health, Joseph served as President, Chief Executive Officer and Director at Angiodynamics (NASDAQ: ANGO) from September 2011 through the summer of 2016. Joseph also held positions as Global President of Smith & Nephew Orthopedics (NYSE: SNN) between 2007 to 2011, President and Chief Executive Officer and Director of RITA Medical Systems, Inc. from 2003 to 2007, President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI) from 2002 to 2003, and Vice President, General Manager at U.S. Surgical/Davis (USS/DG), a division of Tyco International’s Healthcare Business, from 1993 through 2002. Joseph received his Bachelor’s degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond in 1989. Active in industry leadership as well as philanthropy, Joe is a member of the board of Mauna Kea Technologies, (EPA:MKEA) and St. Jude’s Children’s Research Hospital raising over $1,000,000 for the benefit of the Hospital.
Follow Joseph DeVivo:
About AngioDynamics, AngioDynamics, Computer Motion, Inc, InTouch Health, RITA Medical Systems, Inc, SurgiQuest: InTouch Health is the leader in Acute Care Telemedicine solutions.
Surendar Magar
President and CEO of LifeSignals
Surendar Magar has over 30 years’ experience in the technology industry. He co-invented the Texas Instruments TMS320, the groundbreaking digital signal processing architecture that launched the DSP industry. Later he co-founded Athena Semiconductors, an early developer of the wireless networking platform that would become Wi-Fi; Athena was acquired by Broadcom Corporation.
Follow Surendar Magar:
About LifeSignals: LifeSignals’ offers innovation in wearable biosensor technologies to address a broad set of needs and opportunities throughout healthcare.
William Facteau
CEO of Earlens
Follow William Facteau:
About Earlens: Earlens is a privately held medical technology company transforming the hearing experience with the only direct sound delivery system.
Farhad Khosravi
Chairman & CEO of Imperative Care
Farhad Khosravi is the Executive Chairman and Co-Founder at Tulavi Therapeutics.
Follow Farhad Khosravi:
About Access Closure, Embolic Protection, Hotspur Technologies, Imperative Care, Imperative Care, Incept, Instylla, Ocular Therapeutix, Ostial Corporation, Tulavi Therapeutics, Tulavi Therapeutics: Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Christian Gormsen
CEO of Eargo
Growing up across the world, Christian dreamed about a career in the NBA, but alas that was not to be. So, he decided on a wildly successful career in the hearing health and professional services industry instead. Over two decades, Christian has been instrumental in growing the hearing health and professional services market for leading global companies. We lured him from Copenhagen with the promise of a try-out with the Golden State Warriors.
Follow Christian Gormsen:
About Eargo: Eargo makes direct-to-consumer hearing aids, allowing customers to access help for their hearing loss from their homes.
Ben Lewis
CEO of Limbix
Ben Lewis is the co-founder of Tapjoy. He has an undergraduate degree in engineering from the University of Michigan, and his first job out of college was working as an engineer on Xbox Live. After spending some time at Microsoft, he returned to Michigan for his MBA where he focused on entrepreneurship and technology. Ben then moved to Google where he spent 4 years as a Product Manager, working on products such as the Toolbar, Search, and Checkout. Ben left Google to found Tapjoy, which began with the launch of TapDefense. Ben now leads the Tapjoy product team and manages accounts for the top publishers.
Follow Ben Lewis:
About Green Shoots Distribution, Limbix: Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.
Konstantinos Alataris
Founder, CEO of Nesos
Konstantinos Alataris is the President and CEO of the Nevro Corp. Prior to founding Nevro, Dr. Alataris was a venture capitalist with Bay City Capital in San Francisco, focusing on investment and strategic advisory services. He was previously a Business Development Manager with Compass, Guidant’s Corporate Venturing Group, where he analyzed and structured medical device/healthcare investments and evaluated acquisition targets. He was also a Research Fellow at the House Ear Institute, a research center and clinic in Los Angeles. Dr. Alataris holds a Ph.D. in Biomedical Engineering, an MBA, and an M.S. in Electrical Engineering from the University of Southern California. He received a BS in Electrical Engineering and Computer Science from the National Technical University of Athens, Greece.
Follow Konstantinos Alataris:
About Nesos: Nesos develops wearable interfaces and software components for the treatment of neurological disorders.
Joseph Huang
CEO of StartX (Stanford-StartX Fund)
Follow Joseph Huang:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Martyn Gross
Co-Founder & CEO of Zerigo Health
Advisor at Cooler Heads Care & Chief Business Officer at Mindera.
Follow Martyn Gross:
About Dthera Sciences, MiNDERA Corporation, Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Connor Landgraf
Co-Founder & CEO of Eko Health
Connor Landgraf is the co-founder and CEO of Eko.
Follow Connor Landgraf:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Wenbin Jiang
Co-Founder and CEO of Cytek Biosciences
Wenbin Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Follow Wenbin Jiang:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Julia Hu
CEO of Lark
Having been too often sleep deprived and dropping off exercise and diet regimens, Julia’s goal is to make people happier and healthier as the CEO of lark technologies. Named Top 10 Most Innovative CE Companies in the World by Fast Company, lark is a mobile and wireless technology company that uses behavior change to personally coach people to feel great. A serial entrepreneur, she has focused on growing early-stage startups in the consumer products and cleantech space. Prior to lark, she ran global startup incubator Clean Tech Open, her own green buildings startup, and worked in China to build consumer electronics with D.light Design. She received her master’s and bachelor’s degrees at Stanford University and half a MBA from the MIT Sloan (a dropout, but they were kind enough to make lark a casestudy). She was an entrepreneur in residence at Stanford’s StartX incubator, and named Top Woman Entrepreneur Under 40 by Marie Claire Magazine.
Follow Julia Hu:
About Lark: Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
Florian Bohn
CEO & Co-Founder of GuRu
Florian has always felt compelled to understand the way the world works. His curiosity moved him to study Electrical Engineering at Caltech (B.S. Cum Laude), to receive an M.S. in Electrical and Computer Engineering from UC Santa Barbara, and a Ph.D. in Electrical Engineering from Caltech. At GuRu, Florian is thrilled to be building technology that will enrich people’s lives on a global scale. He is also proud to be building a community of passionate and like-minded engineers at the organization. As a co-founder and CEO at GuRu, Florian brings years of technology experience. At Axiom Microdevices, he helped define and implement high-frequency RF integrated circuits which have shipped more than 400 million units. At Agilent Laboratories (formerly HP Labs) he worked on clock and data recovery circuits as well as novel test and measurement systems. As a Caltech Lead Scientific Researcher, Florian guided engineering and operational aspects of implementing the microwave system at Caltech’s Space Solar Power Initiative.
Follow Florian Bohn:
About GuRu: Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Gary Guthart
CEO of Intuitive Surgical
Gary Guthart joined Intuitive Surgical in April 1996. Effective January 2010, Guthart was appointed as Chief Executive Officer. In July 2007, he was promoted to President. Prior to that, in February 2006, Guthart assumed the role of Chief Operating Officer. Prior to joining Intuitive, Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Guthart is currently a member of the Board of Directors of Affymetrix, Inc. He received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.
Follow Gary Guthart:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Richard Lin
CEO & Co Founder of Ombre
Follow Richard Lin:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Fred Moll, M.D
CEO of Hansen Medical
Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical, Inc. (Nasdaq: ISRG). Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.
Follow Fred Moll, M.D:
About Hansen Medical, Hansen Medical, Intuitive Surgical, Johnson & Johnson, Sonder Capital: Hansen Medical designs and manufactures medical robotics for the accurate positioning and control of catheter-based technologies.
Gibb Clarke
CEO and Co-Founder of Blockade Medical
Gibb Clarke is co-founder and CEO of Blockade Medical and has more than 10 years experience as a medical device executive with a specific focus on new technology development for the interventional neurovascular marketplace. Prior to co-founding Blockade, Gibb co-founded Pulsar Vascular, Inc. in 2006. A novel therapeutic approach for challenging and complex cerebral aneurysms. Gibb successfully raised multiple rounds of venture capital as well as helped craft and manage the clinical and regulatory strategy for both CE Mark and US approvals. Prior to Pulsar, Gibb played a critical early role in helping Swedish Medical Center in Seattle, WA, plan for and execute the development of The Seattle Neuroscience Institute, a neuroscience center for excellence. Gibb’s efforts resulted in Swedish Medical investing in excess of $35M into the development of its now flagship neuroscience center located in Seattle, WA. Gibb also spent 8 years in the US Marines Corps serving as a team leader in the elite Marine Recon unit. Military schoolings include Amphibious Recon Course, Army Ranger School, US Navy Dive School, and Army Jump School. Gibb is an avid endurance athlete, having competed in over 200 races.
Follow Gibb Clarke:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Jeffrey Brewer
President & CEO of Bigfoot Biomedical
Follow Jeffrey Brewer:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Don Listwin
CEO of RapidAI
Don Listwin is the CEO of RapidAI. Don Listwin is also a distinguished networking industry veteran with more than 20 years of experience, including a decade at Cisco Systems, and served as president and CEO of Openwave Systems Inc., the world’s leading provider of open software and services for the communications industry. Listwin helped launch NetAid, an innovative nonprofit organization that partners with the United Nations to provide corporations, groups and individuals concrete ways to fight extreme poverty in developing countries. Listwin is the founder of the Canary Foundation and a member of the Board of Trustees at the Fred Hutchinson Cancer Research Center in Seattle Washington.
Follow Don Listwin:
About Canary Foundation, RapidAI: RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.
Billoo Rataul
President & CEO of Paramit Corporation
Billoo Rataul is the President & CEO at Paramit Corporation.
Follow Billoo Rataul:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Kelsey Mellard
CEO & Co-Founder of Sitka
Kelsey Mellard is the CEO and Founder of Sitka, a first-of-its-kind medical vConsults platform and specialty provider network. She launched Sitka in 2018 to help improve access to and delivery of specialty care across the nation. Prior to founding Sitka, Kelsey led Health System Integration at Honor, a comprehensive technology-backed home care company. Before joining the Honor, Kelsey led the development of the Post-Acute Care Center for Research (PACCR), which she served as its Executive Director. Kelsey also served in VP roles at naviHealth, UnitedHealth Group, the Center for Medicare and Medicaid Innovation (CMMI), and held positions at Advisory Board Company, Children’s Mercy Hospitals and Clinics, and Kaiser Family Foundation. Kelsey holds a Bachelor’s of Science Degree in Community Health from Winona State University and a Master’s degree in Public Administration from the University of Kansas. She also currently serves as an adjunct faculty member at Winona State University in the College of Nursing and Health Services.
Follow Kelsey Mellard:
About Sitka, Winona State University: Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.
Mark Mastalir
Co-CEO & Chief Marketing Officer of Halo Neuroscience
Follow Mark Mastalir:
About Halo Neuroscience: Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease
Maryam Ziaei
Co-Founder & Chief Executive Officer of iSono Health
Maryam Ziaei is the Co-Founder & CEO at iSono Health.
Follow Maryam Ziaei:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Ren Menon
Co-Founder and CEO of OrthoFX
Ren Menon is currently serving as the managing director of Silicon Valley Capital where he is leading the firm’s diversification into the health and wellness sectors. Prior to Silicon Valley Capital, Mr. Menon held several leadership roles at Invisalign including head of global product development & innovation, head of North America commercial operations, Director – R & D and more. He played a critical role is helping grow Invisalign’s annual revenues to $900MM+ while attaining a market cap of $7B+. Mr. Menon was also the co-founder/CEO of Goldenslate – a big data analytics powered search engine to empower consumers to make informed, trust based choices when selecting critical care service providers. He exited his stake in Goldenslate through a planned sale. Over his 20 year career, he has held leadership roles in general management, product development, sales & marketing. Mr. Menon is currently a strategic advisor to Kairos society. He also sits on the board of SPCA and several privately held healthcare technology companies.
Follow Ren Menon:
About OrthoFX: Innovation Leader in Clear Aligner Orthodontics
Ritankar Das
Founder & Chief Executive Officer of Dascena
Ritankar Das is the founder and CEO of Dascena
Follow Ritankar Das:
About Dascena: Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Raymond W. Cohen
CEO of Axonics Modulation Technologies
Mr. Raymond Cohen is presently Chief Executive Officer of Vessix Medical, Inc.. He has over 28 years of experience in the medical technology field focused on new product development, creation of intellectual property, venture financing, sales and marketing, strategic planning and mergers and acquisitions. For the decade prior to 2006, Cohen served as Chairman and CEO of Nasdaq-listed Cardiac Science, Inc., which in 2004 was ranked as the 4th fastest growing technology company in North America on Deloitte & Touche’s Fast 500 listing and was recognized by Inc. Magazine on “The Innovation 50 – a listing of the most inventive small companies in entrepreneurial America”. Cohen also serves as member of the board of directors of Cardiogenesis Corp, BioLife Solutions, Inc. and Syncroness, Inc. Mr. Cohen holds a B.S. in Business Management from the State University of New York at Binghamton and is an Accredited Public Company Director.
Follow Raymond W. Cohen:
About Axonics Modulation Technologies, BioLife Solutions: Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Jianlu Ma
CEO of NeuroVasc Technologies
Jim Ma founded Neurovasc Technologies Inc. in August of 2015, with a unique background in serial medical device development, clinical evaluation, and commercialization experience. Prior to starting Neurovasc, Mr. Ma founded Marvel Medical Technologies in 2011 and served as its General Manager. Prior to that, he had worked with several major medical device companies and managed R&D activities for 22 years. Mr. Ma received a Bachelor of Arts degree from Xi’an Technological University and his Master of Science degree from Florida International University. Mr. Ma has 23 issued US patents and over 46 US patent applications related to vascular devices.
Follow Jianlu Ma:
About ev3, NeuroVasc Technologies: NeuroVasc Technologies is a medical device company that develops a catheter-based technology to treat neurovascular diseases.
Dow Wilson
President and Chief Executive Officer of Varian
Dow R. Wilson is president and chief executive officer of Varian Medical Systems, a NYSE-listed medical device manufacturer with more than $3.3 billion in global sales. Varian designs and manufactures advanced equipment and software products for treating cancer with radiation as well as imaging components used in imaging and security applications. Mr. Wilson is also a member of the company’s Board of Directors.
Follow Dow Wilson:
About Varian: Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions.
Tom Afzal
Chief Executive Officer of Novum Medical
Chief Executive Officer and Board Member at Novum Medical, Inc.
Follow Tom Afzal:
About Neuroventis, Novum Medical: Novum Medical develops biocompatible materials with broad applications for musculoskeletal clinical practices.
Jay Wei
CEO/President of Optovue
Jay Wei founded Optovue, Inc., in 2003 to develop the next generation of Ophthalmic OCT instruments. His vision in the clinical use of OCT technology has resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, RTVue®. Jay has been working in ophthalmic instrument development and management since 1992, and he has pioneered the commercialization of optical coherence technology for ophthalmic diagnosis since 1994. Prior to founding Optovue, Jay was a Director of Advanced Development and an OCT Program Manager at Carl Zeiss Meditec (Humphrey Instruments). He led the OCT development from ground zero in 1993 and delivered all prior generations of OCT products to the market. Jay received his Bachelor of Science in Electro-physics from the National Chiao-Tung University in Taiwan, and a Master of Science in Applied Optics from the University of New Mexico. He has been granted over 30 patents in ophthalmic devices and has published research in over 10 peer-reviewed journals.
Follow Jay Wei:
About Optovue: Optovue, an ophthalmic device company, works with eye care professionals to improve diagnosis and therapy of ocular diseases.
Sara Naseri
Co-Founder and CEO of Qvin
Sara Naseri is the Co-Founder and CEO at Qvin.
Follow Sara Naseri:
About Qvin, Stanford University School of Medicine: Qvin is a developer of a smart sanitary pad for women to proactively track their health.
Eric Stone
Chief Executive Officer & Co-founder of Velano Vascular
Eric M. Stone is the Chief Executive Officer at Velano Vascular. A patient advocate and serial healthcare entrepreneur, Stone is a former National Trustee of the Crohn’s and Colitis Foundation. Prior to Velano, he served as Vice President of Sales and Marketing for Molecular Health, and earlier in his career launched a series of pioneering interventional cardiology devices for Abbott while based in Brussels, Belgium and California. Stone was a founding member of Model N’s (NYSE: MODN) Life Sciences division, where he led marketing and business development. Stone began his career in marketing with Trilogy Software, and has since co-founded social sector programs at Harvard and Wharton. He served for a decade on Harvard University’s Alumni Association (HAA) Board of Directors and is a past and current Director and Advisor to multiple healthcare upstarts. Stone received an MBA from The Wharton School, a Master’s from Harvard University, and a BA from the University of Pennsylvania. He lives with his wife and two children in San Francisco.
Follow Eric Stone:
About Velano Vascular: Velano Vascular is a medical device innovator committed to enhancing both inpatient blood collection and vascular access
Tyler Hayes
Co-Founder and CEO of Atom Limbs
Tyler Hayes is the Co-Founder and CEO at Atom Limbs.
Follow Tyler Hayes:
About Atom Limbs: Atom builds mind-controlled artificial limbs, to enable a better human body.
Eric Monsef
Co-Founder and CEO of Atom Limbs
Eric Monsef is the Co-founder and CTO at Atom Limbs.
Follow Eric Monsef:
About Atom Limbs: Atom builds mind-controlled artificial limbs, to enable a better human body.
Lubna Ahmad
Founder & Chief Executive Officer of Invoy
Follow Lubna Ahmad:
About Invoy: Invoy provides personalized, predictive nutrition solutions to help individuals meet their health & wellness goals.
Xingjuan Chao
Co-founder and Chief Executive Officer of Ceribell
Follow Xingjuan Chao:
About Ceribell: Ceribell focuses on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective.
Paul Edalat
Chairman of the Board, Interim CEO, CBDO of Vivera Pharamceuticals
With more than 30 years of brand and product development experience in the nutraceutical, pharmaceutical, and medical device sectors, Mr. Edalat brings a keen eye for business development and growth opportunities to Vivera. His forward-thinking management approach as interim CEO has seen Vivera grow from a single division at its founding to over seven divisions and counting today. Leading Vivera’s business development domestically and internationally, Mr. Edalat works closely with Vivera’s sales and marketing teams to anticipate and meet market demands. With trusted global relationships built over the decades, Mr. Edalat has worked to leverage his connections and expand Vivera’s reach. At home, he has led the Company through innovative research and development, focusing on maintaining Vivera’s core mission – putting patients first. www.pauledalat.com
Follow Paul Edalat:
About Vivera Pharamceuticals: Vivera Pharmaceuticals is an innovative, science-driven pharmaceutical company located in Southern California.
Rami Rostami
Founder / CEO of SensoScientific
Follow Rami Rostami:
About SensoScientific, Technocel, TYLT Ventures, ULTRATOOTH by Biodent: SensoScientific provides calibration services in the Temperature/Humidity Monitoring industry as well as design & manufacture transmitters.
John T. Kilcoyne
CEO of JenaValve Technology
John T. Kilcoyne is the CEO at JenaValve Technology, Inc.
Follow John T. Kilcoyne:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
John Kilcoyne
CEO of JenaValve Technology
Follow John Kilcoyne:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
Victoria Carr-Brendel
Chief Executive Officer of JenaValve Technology
Victoria Carr-Brendel is the chief executive officer of [JenaValve Technology](https://www.crunchbase.com/organization/jenavalve-technology#/entity), a provider of TAVI systems for transapical and transfemoral implantation. Prior to that, she was the general manager of Boston Scientific. Carr-Brendel has over 25 years of medical device leadership experience including the development and commercialization of numerous advanced medical devices across disease states. Carr-Brendel obtained her bachelor’s degree in biology from Monmouth College and master’s degree in microbiology from Iowa State University. She also holds a PhD in immunology from the University of Illinois at Chicago. Carr-Brendel lives in Orange County, California, United States.
Follow Victoria Carr-Brendel:
About JenaValve Technology: JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems for transapical and transfemoral implantation.
Shak Lakhani
CEO & Co-Founder of Avro
Shak Lakhani is the CEO and Co-founder of Avro Life Science, a biotech startup developing skin patches for drug delivery. He developed the first iterations of Avro’s novel drug-delivering polymers and now leads business development and day-to-day operations. He began his research career at the age of 15, spending his summers and after school hours working in the McGuigan Lab for tissue engineering and regenerative medicine at the University of Toronto before founding Avro during his studies in nanotechnology engineering at the University of Waterloo. Shak is an alumni of Y-Combinator, the Creative Destruction Lab and the Bayer Grants4Apps program.
Follow Shak Lakhani:
About Avro: Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly.
Robert Ragusa
Chief Executive Officer of Grail
Follow Robert Ragusa:
About Grail, Illumina: Grail develops a pan-cancer screening test designed to detect cancers at an early stage.
Christopher Thanos
President, CEO, and Cofounder of Actym Therapeutics, Inc.
Christopher Thanos is an inventor of Actym’s core technology, has 18 of years of biotechnology industry experience. Previously, he was appointed Head of Biotherapeutics Discovery at Halozyme (NASDAQ: HALO), leading Immunology, Cell Biology, Protein Engineering and Production efforts to populate HALO’s oncology pipeline. Dr. Thanos is the lead inventor of PEG-ADA2 (US Patent 9,969,998), a checkpoint inhibitor that targets immuno-suppressive adenosine, currently in candidate nomination studies. Translational I/O studies from Dr. Thanos’ group on HALO’s PEG-PH20® therapeutic candidate (Phase III, pancreatic cancer) led to a broad strategic alliance between Halozyme and Genentech to study a combination between Tecentriq® (anti-PDL1) and PEG-PH20® in the clinic across 8 solid tumor types. Dr. Thanos’ group also developed an IDE-approved companion diagnostic currently being used in a global phase 3 pancreatic cancer trial. Before HALO, Dr. Thanos was Head of Protein Engineering at Sutro Biopharma (Nasdaq:STRO). Dr. Thanos is a named inventor on nine issued US patents assigned to Sutro, and is the lead inventor of core platform technology used by both Sutro Biopharma and SutroVax Inc. (US Patent 9,650,621). Prior to that, Dr. Thanos co-founded Catalyst Biosciences (NASDAQ:CBIO), where he participated in raising venture capital, and helped to establish the company’s technology platform. He is a co-inventor of Factor VIIa marzeptacog alfa, currently in Phase II/III clinical trials (purchased by Wyeth/Pfizer, garnering $41.2 million in milestones), Factor IX CB2679d/ISU304, currently in Phase I/II trials, and Factor Xa, currently in pre-clinical development. Dr. Thanos also devoted significant effort to establishing Catalyst’s directed evolution-based, protein engineering platform. Earlier in his career, Dr. Thanos was a National Cancer Institute Postdoctoral Fellow under Professor Jim Wells at UCSF and Sunesis (NASDAQ:SNSS). He earned a Ph.D. in Molecular Biology and Biochemistry from UCLA where he was an NIH Chemistry / Biology Interface Predoctoral Fellow. At UCLA, Dr. Thanos discovered the atomic structure and binding mode of SAM domains- one of the most common protein modules found in eukaryotic cells, work which was prominently featured in Science Magazine. He is a named inventor on 17 issued and multiple pending patent applications in the area of biological and cellular therapeutics and a first author of several peer-reviewed articles in top tier journals. As a recognized thought leader in the field, Dr. Thanos is frequently called upon to present as an invited speaker, workshop leader, and conference chairman at international scientific conferences focused on biological therapeutics to treat cancer.
Follow Christopher Thanos:
About Actym Therapeutics, Inc.: Actym Therapeutics is a privately-held biotech focused on the discovery and development of novel immuno-oncology therapies to treat cancer.
Shaun Rahimi
Founder and CEO of ENSO
Shaun Rahimi is CEO and founder of Thimble Bioelectronics. An award-winning innovator that has worked on the design and development of over 40 different medical devices at start ups since he was 15 years old. He has also held R&D roles at Neuropace, Sadra Medical, Modified Polymer Components and Abbott Labs where he participated in the design and development of novel polymer-based products and manufacturing processes.
Follow Shaun Rahimi:
About ENSO, Innovation Quest: ENSO is a wearable device shown in clinical trials to solve pain better than Vicodin
Joy Weiss
President & CEO of Tempo Automation
Joy Weiss, currently President of Dust Networks at Analog Devices, has held executive leadership positions over the past 35 years at a variety of private and public technology companies. Joy was CEO of Dust Networks, a pioneer in industrial wireless sensor networking, when it was acquired by Linear Technology in 2011, and she has served on the boards of several private companies in Silicon Valley. She is currently on the board of Vigilent and Tempo Automation. Joy is also the Chair of the board of Playworks, a national non-profit based in Oakland, CA. Joy holds a BSEE from the Massachusetts Institute of Technology.
Follow Joy Weiss:
About Analog Devices, InkSpace Imaging, Tempo Automation: Tempo Automation is transforming the way companies innovate and bring new electronic products to market.
Frank Fischer
President and CEO of NeuroPace
Frank Fischer has more than 25 years of senior management experience in the medical device industry. The president and CEO of the biomedical device company NeuroPace, he has served on the company’s board since 1998 and joined the company as its chief executive officer in January 2000. Prior to joining Neuropace, Mr. Fischer was president and chief executive officer of Heartport, Inc., a cardiac surgery company, from May 1998 until September 1999 and served on Heartport’s board of directors. Mr. Fischer was president and chief executive officer and a director of Ventritex, Inc., a company that pioneered implantable cardiac defibrillators, from 1987 until the sale of the company to St. Jude Medical, Inc. in early 1997. Mr. Fischer holds an M.S. in management from Rensselaer Polytechnic Institute. Currently, he serves on the boards of several privately held medical device companies.
Follow Frank Fischer:
About NeuroPace: NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Arash Hakhamian
Co-Founder & CEO of Dentulu
Dr. Arash Hakhamian, known as “Dr. Arash”, is a widely recognized and respected doctor of dental surgery focusing his time and energy in teaching dentists advanced clinical procedures and providing life-changing dentistry to his patients locally and internationally. Dr. Arash also serves as a consultant and teacher to current dentists on how to improve the efficiency and standards of their practice to better serve their patients.
Follow Arash Hakhamian:
About Dentulu: Dentulu is a provider of teledentistry and mobile dentistry technology solutions to existing non-profits around the world.
Dustin Shindo
Chairman and CEO of Pono Pharma
Dustin serves as the Chairman of the Board of Directors of Kai Medical. Dustin founded Hoku Corporation and served as its Chairman of the Board, President, and CEO from March 2001 to March 2010. While serving as Chairman of the Board, President, and CEO at Hoku, Dustin led the company to a successfully IPO on the NASDAQ Global Market. He also partnered with global customers including Sanyo, Nissan, Suntech Power, the US Navy, Solarfun, and others, with contracts totaling $2 Billion. Dustin has previously overseen successful ventures in both the software and manufacturing industries. Dustin has a B.A. in Accounting from the University of Washington and an M.B.A. from the Darden Graduate School of Business Administration at the University of Virginia.
Follow Dustin Shindo:
About Kai Medical, Pono Pharma: Pono Pharma develops and commercializes therapies for certain cancers and other diseases.
Octavian Florescu
CEO of Xip
Follow Octavian Florescu:
About Xip: Xip produces disposable blood analyzers that wirelessly upload lab-quality clinical measurements in minutes.
Jared Seehafer
Co-Founder & CEO of Enzyme
Jared is an 11 year veteran of the medical device and biopharma industries, with a background in product management, medical device software, design assurance and regulatory strategy. His experience ranges from leading spinal cord stimulator programs at St. Jude Neuromodulation (now Abbott), to the UI/UX for the first hybrid closed loop insulin pump at Medtronic Diabetes, to the regulatory strategy for numerous combination drug-device products, including Amgen’s Neulasta Onpro and Repatha Pushtronex. Prior to his experience in the life sciences he trained and worked as a software engineer. He holds a BA from the University of Colorado and an MS in Medical Device Engineering from USC.
Follow Jared Seehafer:
About Enzyme, Village Global: Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
Daniel Hawkins
CEO of Avail Medsystems
Mr.Daniel Hawkins is Founder and Senior Advisor of Shockwave Medical.
Follow Daniel Hawkins:
About Avail Medsystems, Shockwave Medical: Avail Medsystems is a medical technology company that develops telemedicine software for the procedure room.
Clint Carnell
Chief Executive Officer of HydraFacial
Clint was born in Anchorage Alaska but receives no royalties from the pipeline, thus he works for a living as our Chief Executive Officer. He grew up in Washington State and chased a soccer ball well enough to attend Duke University on a scholarship where he received grades good enough to land jobs with the likes of Johnson & Johnson, Chiron, Gambro Healthcare and Bausch &Lomb. He’s always been an entrepreneur starting in his early days when he would skip the school bus, buy jolly ranchers for a nickel and sell them for a quarter. At thirty, he founded Charleston Renal Care, which was acquired by DaVita. This gave him the ability to take a chance and join a VC backed company named Thermage, which went public, made acquisitions, and is now called Solta Medical. In his very spare time, Clint and his wife are busy raising two kids in Park City, Utah. The family has lots of animals affectionately called “the farm”. His biggest fear is breaking all his bones trying to race his kids down the ski slope!
Follow Clint Carnell:
About HydraFacial, HydraFacial: HydraFacial is an FDA registered manufacturer of advanced aesthetic technologies and products.
Matt Angle
CEO of Paradromics
Follow Matt Angle:
About Paradromics: Paradromics is developing high data rate brain computer interfacing technology
Sylvia Kang
Co-Founder & CEO of Mira
Sylvia Kang is the founder and CEO of Quanovate, the company behind Mira.
Follow Sylvia Kang:
About Mira, Quanovate: The first FDA and CE registered comprehensive women’s health and chronic disease monitoring platform with 99% of accuracy
Richard Foust
Chief Executive Officer of MicroTransponder
Richard Foust is the Chief Executive Officer of MicroTransponder. Prior to that, he served as a chief commercial officer at Velano Vascular.
Follow Richard Foust:
About MicroTransponder: MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.
Erik Maltais
CEO of Immertec
If you are reading this you are most likely interested in understanding me better in consideration to join our team, become a customer, invest in our company or collaborate in some way. Instead of a boring you with details of my past accomplishment written by yours truly to highlight my greatness, I will instead share my weaknesses and strengths from my predictive index behavioral pattern assessment summary below. (https://www.predictiveindex.com). Please note these words below are not my own. I hope this information provides some insight into how I behave, so you may better judge our suitability. “A very independent, confident, decisive, self-starter, intense and driving. This individual has a strong sense of urgency, can react and adjust quickly to changing conditions, generate novel ideas, and deal with them swiftly. Strongly venturesome in taking risks and focusing on the future; almost exclusively concerned with where they’re going rather than either how they’ll get there, or where they’ve been. Their drive is directed at getting the important things done. Competitive, ambitious and venturesome, they respond positively and actively to challenge and pressure, always sure of an ability to handle problems and people. This individual is outgoing and poised; a forceful, animated, communicator tending to be more authoritative than persuasive in style. They talk briskly, with assurance and conviction and are a stimulating influence on others, while being direct, determined and flexible. Sure of the value of personal judgments and opinions, and persistent in defending them if put under pressure to change them, Erik will question and challenge established company policies or systems and strive to prove in action the value of their ideas for change. More concerned with the achievement of goals than with the details of how things get done, this individual will freely delegate to others with loose follow-up, but with demand and pressure for timely results. Ingenious and venturesome, they will likely become restless and dissatisfied if required to work under close control or to do work which is routine or highly structured. Very much a generalist, Erik is more concerned with the strategies involved in reaching goals than with specifics or detailed tactics.”
Follow Erik Maltais:
About Bunker Labs, Immertec: Immertec is a real-time virtual observation platform for remote, fully-immersive surgical and medical training.
Keith Grossman
President and CEO of Thoratec Corporation
Follow Keith Grossman:
About Thoratec Corporation: Thoratec Corporation develops, manufactures, and markets medical devices.
Victor McCray
Founder & CEO of Tangible Science
Vic McCray, MD is a Co-Founder of Tangible Science and serves as its President and Chief Executive Officer, where he leads commercialization of technology to improve contact lens comfort for patients suffering from dry eye disease. Involved at the inception, Vic has seen the company through several important milestones including initial proof of concept, venture funding, and the ongoing business development and licensing negotiations.
Follow Victor McCray:
About Santa Clara Valley Medical Center, Stanford Byers Center for Biodesign, Tangible Science: Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.
Anthony P. Ford
Chief Executive Officer of CuraSen Therapeutics
Dr. Ford is co-founder and chief scientific officer of Afferent. An accomplished pharmacologist and former vice president of research at Roche, Dr. Ford initiated and drove the P2X3 program at Roche for over a decade. Dr. Ford brings more than 20 years of research and development experience at Roche and Syntex to Afferent, having led the progression of several novel drug candidates into early clinical development, focused particularly in the areas of pain and genitourinary therapeutics. Dr. Ford was trained in neuropharmacology and holds a Ph.D. from the University of Nottingham (UK).
Follow Anthony P. Ford:
About CuraSen Therapeutics: CuraSen Therapeutics is a biotechnology company.
Orestis Vardoulis
Co-Founder & CEO of Zeit Medical
Orestis Vardoulis currently works as the Co-Founder and CEO for ZeitMedical.
Follow Orestis Vardoulis:
About Zeit Medical: Zeit Medical provides peace of mind to neurology injury patients through powered AI and cutting edge Bioelectronics.
Lea von Bidder
Co-founder & CEO of Ava
Lea co-founded L’inouï, a premium chocolate production and retail chain in Bangalore, India. As COO, she was key to establishing the L’inouï marketing and operation strategy. She holds a Master’s degree in global entrepreneurship from EM Lyon in France, Zhejiang University in China and Purdue Krannert University in the USA. She obtained her Bachelor’s degree from the University of St.Gallen and HEC Montréal in Canada. In between her studies, Lea worked for the marketing division of Procter & Gamble in Frankfurt and for a strategy-consulting boutique in Paris.
Follow Lea von Bidder:
About Ava: Ava is a patented multi-sensor bracelet, which allows women to precisely and conveniently predict fertile days.
Matt Schwartz
Co-founder & CEO of Virgo Surgical Video Solutions
Matt Schwartz is the Co-founder & CEO of Virgo.
Follow Matt Schwartz:
About Virgo Surgical Video Solutions: Virgo accelerates clinical trials with AI for endoscopy
Duke Rohlen
Founder, CEO & Chairman of Ajax Health
Douglas S. Rohlen, also known as Duke, serves as Chief Executive Officer of Ajax Health LLC. Duke Rohlen serves as an Executive Chairman of EPIX Therapeutics, Inc., and has been its Chief Executive Officer. He is a Co-Founder of Ajax Vascular and serves as its Chief Executive Officer. He is a General Partner of D3DC, LLC. He has over two decades of experience in cardiovascular medical devices. He served as the Chief Executive Officer and President at Spirox, Inc. He was a Co-Founder of CV Ingenuity Corp., and served as its President and Chief Executive Officer. He was a Managing Partner of TauTona Group. He served as President of Fox Technologies. He served as Head of Investor Relations at Foxhollow Technologies Inc. He served as President of Strategic Operations at Foxhollow Technologies Inc. Duke Rohlen served as Vice President of Corporate Development and Investor Relations and as Director of Business Development since joining Foxhollow Technologies Inc., he served as President and Chief Executive Officer of Olive Hill Development, a land development company. He served as a Project Consultant at Massachusetts General Hospital. He served as Director of Business Development at LuMend Corporation, a privately-held company that develops chronic total occlusion products in the treatment of peripheral vascular disease which was acquired by Cordis Corporation. In 1999, he served as Entrepreneur in Residence at Alta Partners, a venture capital firm. He served as a Director of Entellus Medical, Inc., Duke Rohlen holds a B.A. in History from Stanford University and an MBA from Harvard Business School.
Follow Duke Rohlen:
About Ablacon, Ajax Health, Atriomx, Cortica, Verix Health: Ajax Health accelerates medical innovation through capital and capabilities.
Philip Sawyer
Chief Executive Officer of Invuity
Philip Sawyer is the CEO at Invuity, Inc.
Follow Philip Sawyer:
About Invuity: Invuity develops illumination and visualization products for minimally invasive surgical field applications.
Michael Kisch
CEO & Board Member of Aktiia
Michael Kisch is the CEO and Board Member at Aktiia.
Follow Michael Kisch:
About Aktiia, Edmund Hillary Fellowship(EHF): 24/7 Blood Pressure Monitoring Made Easy
Ran Ma
Cofounder & CEO of Siren Care
Ran Ma is biomedical engineer and serial entrepreneur with experience in medical device prototyping, project management, business development and marketing. Ran is a skilled networker and effective at finding resources for the team. She has a B.S. in Biomedical Engineering (Johns Hopkins University) and is in the process of finishing her M.S. in Biotechnology (Northwestern University) and M.Sc in Business Administration and Bio-entrepreneurship (CBS). Previously, Ran has developed medical devices for the department of Plastic Surgery at Northwestern University– biomasks to regenerate the human face for war veterans and burn victims. Last year, she was a cofounder and the CMO of Voltset, a Danish consumer electronics startup. She successfully ran the Voltset Kickstarter campaign, which raised $113,548 and reached 192% of the funding goal.
Follow Ran Ma:
About Siren Care: Multi-specialty virtual care clinic leveraging proprietary technology to cost-effectively care for patients at risk of diabetic foot ulcers.
Priya Abani
CEO of AliveCor
Priya Abani is the CEO of AliveCor Inc.Prior to joining AliveCor, Priya served as a general manager at Amazon.
Follow Priya Abani:
About AliveCor: AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
Peter Van Vlasselaer
President and CEO of Arresto BioSciences
Follow Peter Van Vlasselaer:
About ARMO BioSciences, Arresto BioSciences, iPierian: Arresto Biosciences, Inc., a biotechnology company, develops medicines to treat cancer and fibrotic diseases by targeting molecules from
Robert Fenton
Founder & CEO of Qualio
Robert Fenton is the Founder and CEO at Qualio.
Follow Robert Fenton:
About Qualio: Qualio is a quality management system helping life sciences companies bring quality products to the market.
Siva Samy
Founder, CEO, President & Chief Product Strategist of ValGenesis
Follow Siva Samy:
About ValGenesis: Validation Life-cycle Management system
Mike Lynn
CEO of Hound Labs
After leaving the federal government, Dr. Lynn was a visiting scholar at the Center for International Security and Cooperation at Stanford University and an International Affairs Fellow at the Council on Foreign Relations. While at Stanford, he authored various opinion pieces on biosecurity, represented the university at the U.S. government’s TOPOFF 2 national bioterrorism exercise, and gave a keynote address on biosecurity at a Cambridge University intelligence seminar. He continues to support government agencies as required. Dr. Lynn graduated from the University of California, Los Angeles School of Medicine in 1995. He completed his emergency medicine residency at Alameda County Medical Center/Highland General Hospital, one of the premier emergency medicine teaching facilities in the U.S. He has been a Diplomate of the American Board of Emergency Medicine since 2000, a member of the UCSF clinical faculty, and continues to teach and supervise medical students and residents from all over the country at Highland Hospital. In 1988, Dr. Lynn graduated from Carleton College with a B.A. in history and received a Fulbright Scholarship in Sri Lanka. He used his Fulbright award to conduct research on epidemics related to leprosy and AIDS. He also volunteered with UNICEF to bring health resources to civilians struggling to survive a brutal civil war. He later received a Watson Fellowship and an Echoing Green Fellowship to support his work in medicine and public health in other parts of Asia, South America, and Africa. In addition to his role with Hound Labs, Dr. Lynn is a co-founder of the Hound Foundation, a nonprofit established in 2015 to raise awareness about the dangers of driving under the influence of marijuana. Mike is also an active cyclist. Dr. Lynn lives near Oakland, CA with his wife, Jenny, their four children, and a very big Swiss Mountain Dog, Stanley.
Follow Mike Lynn:
About Hound Labs: Hound Labs is a breath technology company that has developed ultra-sensitive technology for non-invasive breath measurement.
Steve Rybka
CEO of Vesalio
Steve Rybka serves as the Chief Executive Officer at Vesalio.
Follow Steve Rybka:
About Vesalio: Vesalio is a privately held medical device company focused on advancing technology needed to improve outcomes in stroke treatment.
Josh Perfetto
Cofounder & CEO of Chai
Follow Josh Perfetto:
About Chai: Chai develops products that make the core biological technologies more useful and readily available to all.
Jack Auld
Co Founder & CEO of Altaviz
Jack is a Co-Founder of Altaviz and well known in the ophthalmic surgical device and instrument market. Jack’s passion is leading high performance teams to solve surgical problems with creative and innovative solutions that yield effective, high-demand products. Prior to founding Altaviz, Jack worked extensively with retina surgeons to deeply understand their objectives, identify their needs and translate those needs into current market-leading, state-of-the art handheld surgical instruments by motivating and guiding teams of talented engineers. 15 successful years in motorsports and specialty vehicle design and development with the Toyota off road racing team and MillenWorks taught Jack to flourish in fast-paced environments and to solve challenging problems. He currently holds 14 US and 7 European patents. Jack graduated from Cal Poly, San Luis Obispo with a BS in Mechanical Engineering. He is married with two children, active in the outdoors and has a passion for ultra light backpacking.
Follow Jack Auld:
About Altaviz, Picocyl: Altaviz develops patent-protected technologies for single-use, custom injection system medical devices.
Bradley E. Patt
Chairman & Chief Executive Officer of TheraCell
Dr. Patt has been chairman of Theracell since it’s inception in 2008 and has served as CEO of the Company since April 2012.
Follow Bradley E. Patt:
About DermOQ, Inc., DxRay Inc., EVO Worldwide, High Beauty, HyVIDA, TheraCell, Thrive Outside The Box: Theracell has two patented platform technologies facilitating stereotactic transplantation of neurons and therapeutic cells into the brain
Satoshi Sugie
Representative Director, CEO, and Founder of WHILL
After working at the NISSAN Technical Center, He co-founded the WHILL Project in 2011.World Economic Forum Davas Meeting and a GSC Japan member.
Follow Satoshi Sugie:
About WHILL: WHILL designs and creates personal mobility products for indoor and outdoor applications.
Dr. Auron Priestley
CEO and Founder of Kolkin
Follow Dr. Auron Priestley:
About Kolkin: Kolkin is a cloud-based care coordination solution that offers a clinical workflow software.
Atsushi Nakanishi
CEO of Triple W Japan
Follow Atsushi Nakanishi:
About Triple W Japan: Triple W Japan makes the world’s first toilet timing predicting device.
John Klock
Chief Executive Officer and Chief Medical Officer of QT Ultrasound
Klock has served as Chief Executive Officer of the Company since 2014 and as Managing Director, Manager and Founder of the Company since 2011. Prior to QT Ultrasound, Dr. Klock was involved in the start-up of five medical companies, including Co-Founder and President of BioMarin Pharmaceutical, which successfully commercialized five FDA approved drugs; Scientific Founder and Vice President of Research of Glycomed, now Ligand Pharmaceutical; and founding investor in Ultragenyx Pharmaceutical. He also personally brought to market a novel cancer treatment, the first rapid AIDS test, comprehensive tests for detecting metabolic diseases in children, and several drugs for treating pediatric genetic conditions. Dr. Klock has authored over 70 peer-reviewed medical and scientific publications, and eight granted patents.
Follow John Klock:
About QT Ultrasound: A research and development company.
Scott Kim
CEO of Neofect
Follow Scott Kim:
About Neofect: Neofect develops innovative home exercise device and software for stroke survivors’ fast recovery and rehabilitation.
Todd Powell
President & CEO of RefleXion Medical
Todd Powell has been Chief Executive Officer and President at RefleXion Medical Inc. Todd Powell spent 29 years developing innovative products while leading global organizations in cancer care. He served as an Executive Vice President of Global Engineering at Elekta AB (publ). He worked at IMPAC Medical Systems, a leader in information systems for radiation and medical oncology. he became Vice President of Product Engineering & Development and was involved with the company’s successful public offering and subsequent acquisition by Elekta. He began his career as an Oncology Marketing and Business Specialist at Varian Medical Systems. He served as an Executive Vice President of Comprehensive Oncology Solutions at Elekta AB. He served as an Executive Vice President of Elekta Software at Elekta AB. He has been with Elekta AB for the past 18 years and served as its Acting Executive Vice President of Elekta Software. He served as Senior Vice President of Software Systems. He has been a Director at RefleXion Medical Inc. Todd Powell holds a BSc Hons in Mathematics and High energy physics from California State University.
Follow Todd Powell:
About RefleXion Medical: RefleXion Medical is a developer of biologically-guided radiotherapy systems for patients with cancer.
Thilo Hölscher
CEO, CMO, Co-Founder of Burl Concepts
Follow Thilo Hölscher:
About Burl Concepts: Burl Concepts manufactures portable battery-powered ultrasound device for non-invasive and transcranial diagnosis of strokes.
